Chen et al., 2021
Featured review: Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease
Yaojing Chen, Mingxi Dang & Zhanjun Zhang
Xia et al. 2021
Featured Review: “Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
Yuxing Xia, Stefan Prokop & Benoit I. Giasson
West et al. 2021
Sarkar et al., 2021
Featured Research: Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo
Souvarish Sarkar, ... & Mel B. Feany
Articles
-
-
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
-
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
-
Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: a systematic review of symptom-general and –specific lesion patterns
-
Neuroprotection by WldS depends on retinal ganglion cell type and age in glaucoma
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
α-Synuclein and neuronal cell death
-
The neuropathological diagnosis of Alzheimer’s disease
-
Exosomal cell-to-cell transmission of alpha synuclein oligomers
-
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
Editor highlights
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
-
-
-
A New Era of Alzheimer’s Treatment
23 June 2021
Contact the Managing Editorial Team
Hongmei Li - Hongmei.Li@MolecularNeurodegeneration.org
Lucy Job - Lucy.Job@MolecularNeurodegeneration.org
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Follow
Annual Journal Metrics
-
Speed
58 days to first decision for reviewed manuscripts only
31 days to first decision for all manuscripts
153 days from submission to acceptance
28 days from acceptance to publication
Citation Impact
9.599 - 2-year Impact Factor
8.595 - 5-year Impact Factor
1.671 - Source Normalized Impact per Paper (SNIP)
4.040 - SCImago Journal Rank (SJR)
Usage
770,533 downloads
723 Altmetric mentions